Incyte Corporation revenue breakdown overview

Incyte Corporation revenue for the last year amounted to 4.24 B USD, the most of which — 4.27 B USD — came from its highest performing source at the moment, Oncology and Dermatology Pharmaceutical Products, the year earlier bringing 3.68 B USD. The greatest contribution to the revenue figure was made by United States — last year it brought Incyte Corporation 4.00 B USD, and the year before that — 3.50 B USD.